These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18240144)

  • 21. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
    Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M
    Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
    Schmelz K; Wagner M; Dörken B; Tamm I
    Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).
    Inchakalody VP; Hydrose SP; Krishnankutty R; Merhi M; Therachiyil L; Sasidharan Nair V; Elashi AA; Khan AQ; Taleb S; Raza A; Yoosuf ZSKM; Fernandes Q; Al-Zaidan L; Mestiri S; Taib N; Bedhiafi T; Moustafa D; Assami L; Maalej KM; Elkord E; Uddin S; Al Homsi U; Dermime S
    Eur J Pharmacol; 2023 Apr; 945():175612. PubMed ID: 36822455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma.
    Xiao WH; Sanren GW; Zhu JH; Li QW; Kang HR; Wang RL; Song LP; Ye M
    World J Gastroenterol; 2010 May; 16(19):2371-7. PubMed ID: 20480522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged upregulation of the expression of HLA class I antigens and costimulatory molecules on melanoma cells treated with 5-aza-2'-deoxycytidine (5-AZA-CdR).
    Coral S; Sigalotti L; Gasparollo A; Cattarossi I; Visintin A; Cattelan A; Altomonte M; Maio M
    J Immunother; 1999 Jan; 22(1):16-24. PubMed ID: 9924695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1.
    Weiser TS; Guo ZS; Ohnmacht GA; Parkhurst ML; Tong-On P; Marincola FM; Fischette MR; Yu X; Chen GA; Hong JA; Stewart JH; Nguyen DM; Rosenberg SA; Schrump DS
    J Immunother; 2001; 24(2):151-61. PubMed ID: 11265773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demethylating agent decitabine induces autologous cancer testis antigen specific cytotoxic T lymphocytes in vivo.
    Zhou JH; Yao YS; Wang LX; Wang J; Li YH; Jiang MM; Zhou MH; Gao XN; Li RS; Wang LL; Yu L
    Chin Med J (Engl); 2013 Dec; 126(23):4552-6. PubMed ID: 24286424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma.
    Lai TJ; Sun L; Li K; Prins TJ; Treger J; Li T; Sun MZ; Nathanson DA; Liau LM; Lai A; Prins RM; Everson RG
    Cancer Res Commun; 2024 Jul; 4(7):1834-1849. PubMed ID: 38856710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor.
    Dubovsky JA; McNeel DG
    Prostate; 2007 Dec; 67(16):1781-90. PubMed ID: 17929270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.
    Shraibman B; Kadosh DM; Barnea E; Admon A
    Mol Cell Proteomics; 2016 Sep; 15(9):3058-70. PubMed ID: 27412690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
    Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
    Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1.
    Krishnadas DK; Bao L; Bai F; Chencheri SC; Lucas K
    Tumour Biol; 2014 Jun; 35(6):5753-62. PubMed ID: 24584817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fusion of NY-ESO-1 epitope with heat shock protein 70 enhances its induced immune responses and antitumor activity against glioma
    Chen Y; Zheng L; Hua W; Wang J; Chen L; Huang A; Zhang W
    Transl Cancer Res; 2024 Jan; 13(1):191-201. PubMed ID: 38410235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5-aza-2'-deoxycytidine suppresses the growth of human lung adenocarcinoma cells in nude mouse xenograft models and its effect on methylation status and expression of TFPI-2 gene].
    Liang J; Yin G; Dong Y; Ma Z; Xiao Y; Ji T
    Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):485-9. PubMed ID: 26463322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.
    Griffiths EA; Srivastava P; Matsuzaki J; Brumberger Z; Wang ES; Kocent J; Miller A; Roloff GW; Wong HY; Paluch BE; Lutgen-Dunckley LG; Martens BL; Odunsi K; Karpf AR; Hourigan CS; Nemeth MJ
    Clin Cancer Res; 2018 Mar; 24(5):1019-1029. PubMed ID: 28947565
    [No Abstract]   [Full Text] [Related]  

  • 37. 5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.
    Hagiwara H; Sato H; Ohde Y; Takano Y; Seki T; Ariga T; Hokaiwado N; Asamoto M; Shirai T; Nagashima Y; Yano T
    Br J Pharmacol; 2008 Apr; 153(7):1373-81. PubMed ID: 18264126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
    Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Blagitko-Dorfs N; Ford LA; Naqash R; Lübbert M; Karpf AR; Nemeth MJ; Griffiths EA
    Oncotarget; 2016 Mar; 7(11):12840-56. PubMed ID: 26883197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents.
    Mirza S; Sharma G; Pandya P; Ralhan R
    Mol Cell Biochem; 2010 Sep; 342(1-2):101-9. PubMed ID: 20455010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
    Shen WJ; Dai DQ; Teng Y; Liu HB
    World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.